Learn About the Law
Get help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
Thomas CUNNINGHAM, Individually and On Behalf of All Others Similarly Situated, Plaintiff-Appellant, v. IDENTIV, INC.; et al., Defendants-Appellees.
MEMORANDUM **
In this putative class action, lead plaintiff Thomas Cunningham appeals the district court's dismissal of his Second Amended Complaint alleging securities fraud by Identiv Inc., Identiv's former CEO Jason Hart, and Identiv's former CFO Brian Nelson in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. See 15 U.S.C. §§ 78j(b), 78t(a); 17 C.F.R. § 240.10b–5. Because the parties are familiar with the facts, we do not recite them here. We have jurisdiction under 28 U.S.C. § 1291, and we affirm.
We review de novo the district court's dismissal for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6). Colony Cove Props., LLC v. City of Carson, 640 F.3d 948, 955 (9th Cir. 2011).
Cunningham failed to adequately plead scienter as required by Federal Rule of Civil Procedure 9(b) and the Private Securities Litigation Reform Act of 1995. Fed. R. Civ. P. 9(b); 15 U.S.C. § 78u-4(b); see also Erica P. John Fund, Inc. v. Halliburton Co., 563 U.S. 804, 809–10, 131 S.Ct. 2179, 180 L.Ed.2d 24 (2011) (listing the required elements of a private securities fraud claim). Cunningham failed to allege specific facts giving rise to a strong inference, “at least as compelling as any opposing inference,” that the defendants acted with contemporaneous intent to defraud investors. Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308, 314, 324, 127 S.Ct. 2499, 168 L.Ed.2d 179 (2007).
Nor did Cunningham adequately plead loss causation. See Lloyd v. CVB Fin. Corp., 811 F.3d 1200, 1209 (9th Cir. 2016). Cunningham failed to establish a “causal connection between [a] material misrepresentation and the loss” faced by the plaintiffs. Dura Pharm., Inc. v. Broudo, 544 U.S. 336, 342, 125 S.Ct. 1627, 161 L.Ed.2d 577 (2005). The second amended complaint lacked specific facts indicating that “the decline in the defendant's stock price was proximately caused by a revelation of fraudulent activity rather than by changing market conditions, changing investor expectations, or other unrelated factors.” Loos v. Immersion Corp., 762 F.3d 880, 887 (9th Cir. 2014).1
We adopt the detailed and well-reasoned analysis in the district court's order entered January 4, 2017.
AFFIRMED.
FOOTNOTES
1. Because Cunningham fails to allege a primary violation, his claim for control person liability under Section 20(a) also fails. Lipton v. Pathogenesis Corp., 284 F.3d 1027, 1035 n. 15 (9th Cir. 2002); 15 U.S.C. § 78t(a).
Thank you for your feedback!
A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes visit FindLaw's Learn About the Law.
Docket No: No. 17-15220
Decided: March 23, 2018
Court: United States Court of Appeals, Ninth Circuit.
Search our directory by legal issue
Enter information in one or both fields (Required)
Harness the power of our directory with your own profile. Select the button below to sign up.
Learn more about FindLaw’s newsletters, including our terms of use and privacy policy.
Get help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
Search our directory by legal issue
Enter information in one or both fields (Required)